Investor
The company's complete blood count analyzer uses artificial intelligence to quickly measure biomarkers from a fingerstick or venous sample.
Each Livongo share will be converted Teladoc stock at a 0.5920 exchange rate, plus an additional $11.44 in cash per stock.
The listing could happen either later this year or in early 2021, Reuters reports.
A majority of femtech funding goes towards fertility, pregnancy or motherhood, leaving many other women’s health areas underserved, according to Rock Health.
The regulator said it was not satisfied with Google's offer to silo Fitbit-collected data so that it could not be used for advertising purposes.
Also: VillageMD's new chief innovation officer, and Hims & Hers brings on behavioral health expertise.
The startup's approach combines a low-cost digital-imaging device for hospitals with a comprehensive medical-imaging software platform.
The new service will let patients communicate with general practitioners, mental health clinicians and specialists.
The company will join the Nasdaq with an initial valuation around $720 million.
Also: DarioHealth announced $28.6 million private placement transaction; StuffThatWorks launches with $9 million seed funding.